Improving estimation of Parkinson's disease risk-the enhanced PREDICT-PD algorithm.


Journal

NPJ Parkinson's disease
ISSN: 2373-8057
Titre abrégé: NPJ Parkinsons Dis
Pays: United States
ID NLM: 101675390

Informations de publication

Date de publication:
01 Apr 2021
Historique:
received: 10 08 2020
accepted: 22 02 2021
entrez: 2 4 2021
pubmed: 3 4 2021
medline: 3 4 2021
Statut: epublish

Résumé

We previously reported a basic algorithm to identify the risk of Parkinson's disease (PD) using published data on risk factors and prodromal features. Using this algorithm, the PREDICT-PD study identified individuals at increased risk of PD and used tapping speed, hyposmia and REM sleep behaviour disorder (RBD) as "intermediate" markers of prodromal PD in the absence of sufficient incident cases. We have now developed and tested an enhanced algorithm which incorporates the intermediate markers into the risk model. Risk estimates were compared using the enhanced and the basic algorithm in members of the PREDICT-PD pilot cohort. The enhanced PREDICT-PD algorithm yielded a much greater range of risk estimates than the basic algorithm (93-609-fold difference between the 10th and 90th centiles vs 10-13-fold respectively). There was a greater increase in the risk of PD with increasing risk scores for the enhanced algorithm than for the basic algorithm (hazard ratios per one standard deviation increase in log risk of 2.75 [95% CI 1.68-4.50; p < 0.001] versus 1.47 [95% CI 0.86-2.51; p = 0.16] respectively). Estimates from the enhanced algorithm also correlated more closely with subclinical striatal DaT-SPECT dopamine depletion (R

Identifiants

pubmed: 33795693
doi: 10.1038/s41531-021-00176-9
pii: 10.1038/s41531-021-00176-9
pmc: PMC8017005
doi:

Types de publication

Journal Article

Langues

eng

Pagination

33

Subventions

Organisme : Parkinson's UK
ID : G-1606
Pays : United Kingdom
Organisme : Parkinson's UK
ID : G-1606
Pays : United Kingdom

Références

Mov Disord. 2012 Mar;27(3):406-12
pubmed: 22237833
J Nucl Med. 2013 May;54(5):714-22
pubmed: 23492885
Mov Disord. 2015 Oct;30(12):1600-11
pubmed: 26474317
Mov Disord. 2018 Mar;33(3):405-413
pubmed: 29436728
Ann Neurol. 2012 Dec;72(6):893-901
pubmed: 23071076
Mov Disord. 2019 Oct;34(10):1464-1470
pubmed: 31412427
Physiol Behav. 1984 Mar;32(3):489-502
pubmed: 6463130
BMJ. 2006 May 6;332(7549):1080
pubmed: 16675816
PLoS One. 2014 Apr 29;9(4):e96260
pubmed: 24781810
Mov Disord. 2018 Mar;33(3):478-482
pubmed: 29380907
NPJ Parkinsons Dis. 2019 Mar 27;5:4
pubmed: 30937360
Mov Disord. 2017 Feb;32(2):219-226
pubmed: 28090684
J Neurol Neurosurg Psychiatry. 2014 Jan;85(1):31-7
pubmed: 23828833
Mov Disord. 2007 Dec;22(16):2386-93
pubmed: 17894337

Auteurs

Jonathan P Bestwick (JP)

Preventive Neurology Unit, Wolfson Institute of Preventive Medicine, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.

Stephen D Auger (SD)

Preventive Neurology Unit, Wolfson Institute of Preventive Medicine, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.

Cristina Simonet (C)

Preventive Neurology Unit, Wolfson Institute of Preventive Medicine, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.

Richard N Rees (RN)

Department of Clinical and Movement Neuroscience, UCL Institute of Neurology, University College London, London, UK.

Daniel Rack (D)

Barts and The London School of Medicine and Dentistry, Queen Mary University, London, UK.

Mark Jitlal (M)

Preventive Neurology Unit, Wolfson Institute of Preventive Medicine, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.

Gavin Giovannoni (G)

Preventive Neurology Unit, Wolfson Institute of Preventive Medicine, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University, London, UK.

Andrew J Lees (AJ)

Department of Clinical and Movement Neuroscience, UCL Institute of Neurology, University College London, London, UK.

Jack Cuzick (J)

Preventive Neurology Unit, Wolfson Institute of Preventive Medicine, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.

Anette E Schrag (AE)

Department of Clinical and Movement Neuroscience, UCL Institute of Neurology, University College London, London, UK.

Alastair J Noyce (AJ)

Preventive Neurology Unit, Wolfson Institute of Preventive Medicine, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK. a.noyce@qmul.ac.uk.
Department of Clinical and Movement Neuroscience, UCL Institute of Neurology, University College London, London, UK. a.noyce@qmul.ac.uk.

Classifications MeSH